|
|
HIV-Positive Women Started on PI-Based HAART Have Highest CD4 Cell Counts
|
| Link ID |
2966 |
| Title |
HIV-Positive Women Started on PI-Based HAART Have Highest CD4 Cell Counts |
| Url |
http://www.medscape.com/viewarticle/569675?src=rss |
| Description |
Initial highly active anti-retroviral treatment (HAART) regimens that include protease inhibitors (PIs) result in significantly higher CD4+ cell counts at 2 years among HIV-positive women compared with regimens based on non-nucleoside reverse transcriptase inhibitors (NNRTIs) or triple-nucleoside reverse transcriptase inhibitors (NRTIs), according to a new study. Reuters Health Information |
| Category |
Articles > HIV/AIDS |
| Keywords |
|
| Date |
Feb 5, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > HIV/AIDS |
| 4. |
Memantine May Benefit Cognitively Impaired AIDS Patients
|
|
|
Memantine, an uncompetitive antagonist of the N-methyl-D-aspartate receptor, might ameliorate HIV-associated cognitive impairment, researchers report. Although their 16-week study showed no clear clinical benefit, possible neuroprotective action was demonstrated by proton magnetic resonance spectroscopy (MRS). Reuters Health Information
|
|
|